Stillbirth Risk Identification Using Multiparametric Ultrasound
STIMULUS
1 other identifier
observational
282
1 country
1
Brief Summary
The goal of this observational study is to identify a novel biomarker for stillbirth. Specifically the aim is to predict perinatal hypoxia using quantitative ultrasound from the placenta (QUS-P) between 35 and 37 weeks gestation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 3, 2023
CompletedFirst Submitted
Initial submission to the registry
April 1, 2025
CompletedFirst Posted
Study publicly available on registry
April 16, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2025
CompletedApril 16, 2025
April 1, 2025
2.6 years
April 1, 2025
April 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Presence of Perinatal Hypoxia at 35-37 weeks gestation
Perinatal hypoxia is defined as meeting one or more of the following: 1. Apgar \< 7 at 5 minutes 2. Umbilical artery pH \< 7.1 3. Neonatal cardiac resuscitation performed (includes CPAP, intubation and ventilation, or cardiopulmonary resuscitation) 4. Neonatal encephalopathy (Severe brain injury diagnosed within the first 7 days of life defined as: was therapeutically cooled; and/or had decreased central tone or was comatose and had seizures of any kind; and/or had amplitude integrated electroencephalography (aEEG abnormality) in the first 24 hours of birth. )
35-37 weeks gestation
Eligibility Criteria
Potential participants are recruited from the following sources: 1. South Community Birth Program 2. Maternal Fetal Medicine Clinics at BC Women's Hospital (EMMA and Fetal Monitoring)
You may qualify if:
- Pregnant with singleton
- Age 19 years or older
- Provision of informed consent
- Planning to deliver at BC Women's Hospital
- weeks gestation or less
You may not qualify if:
- Pregnant with multiples
- Not planning to deliver at BC Women's Hospital
- Less than 19 years of age
- Greater than 38 weeks gestation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of British Columbialead
- Wellcome Trustcollaborator
Study Sites (1)
South Community Birth Program
Vancouver, British Columbia, V5V 3C9, Canada
Biospecimen
placenta
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Robert Rohling, PhD
The University of British Columbia
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 1, 2025
First Posted
April 16, 2025
Study Start
January 3, 2023
Primary Completion
July 30, 2025
Study Completion
September 30, 2025
Last Updated
April 16, 2025
Record last verified: 2025-04